MSS/ MMRp

Who we are

  • April 5, 2022
    Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study
  • April 5, 2022
    LT for Unresectable Colorectal Liver Metastasis
  • April 5, 2022
    Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
  • April 5, 2022
    Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
  • April 5, 2022
    Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
  • April 5, 2022
    Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
  • April 5, 2022
    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
  • April 5, 2022
    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
  • April 5, 2022
    Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
  • April 5, 2022
    Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer